J.Safra Asset Management »

Miragen Therapeutics shares owned by J.Safra Asset Management

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by J.Safra Asset Management from 13F filings

Historical chart of J.Safra Asset Management investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by J.Safra Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by J.Safra Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.9k 180 21.58
2025-06-30 $2.5k 180 13.98
2025-03-31 $2.4k 180 13.48
2024-12-31 $409 21 19.52
2024-09-30 $326 14 23.36

More positions owned by J.Safra Asset Management

Invesco Qqq Tr Unit Ser 1 Unit Ser 1 (QQQ)
Select Sector Spdr Trust The Technology Select Sector Spdr Fund Technology (XLK)
Ishares Russell 1000 Growth Etf Rus 1000 Grw Etf (IWF)
Select Sector Spdr Trust The Communication Services Select Sector Spdr Fund Communication (XLC)
Listed Funds Trust Roundhill Magnificent Seven Etf Roundhill Magnif (MAGS)
Select Sector Spdr Trust The Financial Select Sector Spdr Fund Financial (XLF)
Ishares Msci All Country Asia Ex Japan Index Fund Msci Ac Asia Etf (AAXJ)
Vanguard Intl Equity Ind Fd Ftse All World Ex Us Fd Etf Allwrld Ex Us (VEU)
Select Sector Spdr Trust The Energy Select Sector Spdr Fund Energy (XLE)
Select Sector Spdr Trust The Health Care Select Sector Spdr Fund Sbi Healthcare (XLV)
Spdr S&p Dividend Etf S&P Divid EFT (SDY)
Select Sector Spdr Trust The Industrial Select Sector Spdr Fund Indl (XLI)
Spdr S&p 500 Etf Trust Etf Tr Unit (SPY)
Spdr Ser Tr S&p Ins Etf S&p Ins Etf (KIE)
Vaneck Etf Tr Vaneck Semiconductor Etf Semiconductr Etf (SMH)

View all positions for J.Safra Asset Management

Top funds holding Miragen Therapeutics

FMR
BlackRock
Deep Track Capital
Kynam Capital Management
Vanguard Group
VR Adviser
Fairmount Funds Management
Commodore Capital
Tang Capital Management
Paradigm Biocapital Advisors
State Street Corporation
Novo A/S
Maverick Capital
Eversept Partners
Alliancebernstein

View all funds holding Miragen Therapeutics